PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-04-22

Date Title Company
22-Apr-2026 Ondine Biomedical Announces Selection of Two Abstracts for Presentation at the 2026 World Congress on Infectious Diseases Ondine Biomedical
22-Apr-2026 2cureX AB completes oversubscribed directed issue 2cureX AB
22-Apr-2026 Evonik strengthens biotechnology capabilities for drug substance manufacturing with new investment in Slovakia Evonik
22-Apr-2026 A National Genomics Study Advances Early Detection and Prevention of Vision Loss M42
22-Apr-2026 Eurofins Achieves Organic Growth of 2.6% in Q1 2026, Including Impact of Exceptionally Severe Weather; 2026 and Mid-Term Objectives Reiterated Businesswire
22-Apr-2026 Yaqrit Phase 2a data, clinical consensus boost YAQ007 and YAQ006 in Hepatic Encephalopathy Yaqrit
22-Apr-2026 4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis Businesswire
22-Apr-2026 Faron Pharmaceuticals Ltd: Holding(s) in Company ACCESS Newswire
22-Apr-2026 Black Book Research: Croatia Healthcare IT Shifts From Digitization to Execution ACCESS Newswire
22-Apr-2026 CBD Life Sciences Inc. (CBDL) Enters into Stock Purchase Agreement with FBC Holding Inc. to Acquire Mushroom Madness Inc. and Formrunner Apparel; Subsidiaries Now 100% Wholly Owned ACCESS Newswire
22-Apr-2026 Lentiviral Vector CDMO Market: Growth, Trends, and Forecast to 2030 Medi-Tech Insights
22-Apr-2026 Custom Antibody Market: Innovation, Opportunities, and Challenges Medi-Tech Insights
22-Apr-2026 Insulin Pumps Market - Market Analysis, Size, Share, Growth, Trends and Forecast – 2031 Medi-Tech Insights
22-Apr-2026 Biobanking Market Trends, Demand and Business Opportunities 2031 Medi-Tech Insights
22-Apr-2026 Vicore Pharma Completes Enrollment in the Phase 2b ASPIRE Trial of Buloxibutid in Idiopathic Pulmonary Fibrosis ACCESS Newswire
22-Apr-2026 Margins Strengthened and Cash Flow Improved Despite a Temporary Dip in The Growth Trajectory. Full-Year Targets Remain on Track ACCESS Newswire
22-Apr-2026 Nanomerics Secures US Patent Extending MET Platform Protection to the 2040s ACCESS Newswire